News
Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward ...
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
18h
BUCKSCO.Today on MSNBucks County Officials Sue Insulin Manufacturers and Drug Price Negotiators Over ‘Illegal Price-Fixing Scheme’Bucks County has joined municipalities across the nation in suing major insulin manufacturers and drug price negotiating ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
HONG KONG (AP) — Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’s Ratings downgraded the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results